S
Sava Technologies
$54.9M raised across 2 rounds tracked here. Latest: Series B, $35.9M on 9 October 2026.
Rounds 2
$35.9MSeries B, 9 October 2026
Sava Technologies raised €32.08 million in Series B funding led by Ascensia to scale manufacturing and prepare its glucose microsensor for commercialization.
- Amount
- $35.9M
- Stage
- Series B
- Announced
- 9 October 2026
- Investors
- Ascensia, Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments, Pentland Ventures
- Checked
- Amount and date checked against the press source
- Source
- London’s Sava raises €32.08 million and partners with Ascensia to bring its glucose microsensor to Europe eu-startups.com
$19MSeries A, 31 July 2025
Funds team growth, manufacturing and regulatory approval of its wearable.
- Amount
- $19M
- Stage
- Series A
- Announced
- 31 July 2025
- Lead
- Balderton Capital
- Other investors
- Pentland Ventures, Norrsken VC, JamJar Investments, Italian Founders Fund
- Use of funds
- Funds team growth, manufacturing and regulatory approval of its wearable.
- Checked
- Announced by the company
- Sources
- Sava raises €16.6M balderton.com
Sava raises €16.6M siliconcanals.com
Company
Develops wearable biosensors that continuously detect glucose and other molecules
- Based in
- London, 🇬🇧United Kingdom
- Sector
- Health
- Website
- sava.health ↗
Questions
How much has Sava Technologies raised?
Sava Technologies has raised $54.9M across 2 rounds tracked by FundraiseBase. The latest is Series B of $35.9M, announced on 9 October 2026.
Who invested in Sava Technologies?
Balderton Capital led. Investors include Ascensia, Balderton Capital, Norrsken VC, Simplyhealth Ventures, JamJar Investments and Pentland Ventures.
